Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Furer V, Eviatar T, Zisman D, Peleg H, Paran D, Levartovsky D, Zisapel M, Elalouf O, Kaufman I, Meidan R, Broyde A, Polachek A, Wollman J, Litinsky I, Meridor K, Nochomovitz H, Silberman A, Rosenberg D, Feld J, Haddad A, Gazzit T, Elias M, Higazi N, Kharouf F, Shefer G, Sharon O, Pel S, Nevo S, Elkayam O. Furer V, et al. Among authors: zisapel m. Ann Rheum Dis. 2021 Oct;80(10):1330-1338. doi: 10.1136/annrheumdis-2021-220647. Epub 2021 Jun 14. Ann Rheum Dis. 2021. PMID: 34127481
Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab.
Furer V, Eviatar T, Zisman D, Peleg H, Braun-Moscovici Y, Balbir-Gurman A, Paran D, Levartovsky D, Zisapel M, Elalouf O, Kaufman I, Broyde A, Polachek A, Feld J, Haddad A, Gazitt T, Elias M, Higazi N, Kharouf F, Pel S, Nevo S, Elkayam O. Furer V, et al. Among authors: zisapel m. Vaccines (Basel). 2022 Jun 6;10(6):901. doi: 10.3390/vaccines10060901. Vaccines (Basel). 2022. PMID: 35746508 Free PMC article.
Prevalence of TNF-α blocker immunogenicity in psoriatic arthritis.
Zisapel M, Zisman D, Madar-Balakirski N, Arad U, Padova H, Matz H, Maman-Sarvagyl H, Kaufman I, Paran D, Feld J, Litinsky I, Wigler I, Caspi D, Elkayam O. Zisapel M, et al. J Rheumatol. 2015 Jan;42(1):73-8. doi: 10.3899/jrheum.140685. Epub 2014 Nov 15. J Rheumatol. 2015. PMID: 25399390
Case report: Cerebral sinus vein thrombosis in VEXAS syndrome.
Zisapel M, Seyman E, Molad J, Hallevi H, Mauda-Havakuk M, Jonas-Kimchi T, Elkayam O, Eviatar T. Zisapel M, et al. Front Med (Lausanne). 2024 Apr 8;11:1377768. doi: 10.3389/fmed.2024.1377768. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38651063 Free PMC article.
Ocular and orbital manifestations in VEXAS syndrome.
Abumanhal M, Leibovitch I, Zisapel M, Eviatar T, Edel Y, Ben Cnaan R. Abumanhal M, et al. Among authors: zisapel m. Eye (Lond). 2024 Mar 28. doi: 10.1038/s41433-024-03014-3. Online ahead of print. Eye (Lond). 2024. PMID: 38548942
Systemic Lupus Erythematous and Obstructive Sleep Apnea: A Possible Association.
Meidan R, Elalouf O, Tauman R, Furer V, Polachek A, Wollman J, Eviatar T, Zisapel M, Levartovsky D, Seyman E, Elkayam O, Paran D. Meidan R, et al. Among authors: zisapel m. Life (Basel). 2023 Mar 5;13(3):697. doi: 10.3390/life13030697. Life (Basel). 2023. PMID: 36983852 Free PMC article.